Sunrisecontent

Sunrise Remedies offers high-quality Lamivudine and Zidovudine combination tablets, a cornerstone of antiretroviral therapy (ART) for managing HIV-1 infection. This potent dual-action formulation works by inhibiting the reverse transcriptase enzyme, effectively preventing viral replication and strengthening the immune system. Manufactured in our WHO-GMP certified facility, our tablets ensure international safety and efficacy standards. By reducing viral load and increasing CD4 cell counts, this medication helps delay the progression of HIV to AIDS and improves long-term patient health outcome

ZioTripal Tablets are widely supplied for use within structured HIV management programs overseen by medical professionals. These tablets are manufactured under controlled forms outlined to keep up consistency and consistency over bunches. For healthcare systems managing long-term treatment programs, progression of supply is just as important as quality, and ZioTripal Tablets help address this requirement.

By maintaining stable production and careful monitoring at every stage, Sunrise Remedies Pvt Ltd ensures that ZioTripal Tablets meet the expectations of international procurement agencies

Zidosun is a brand name for the medication zidovudine, a drug used in the management and treatment of HIV-1 infection. It is classified as a nucleoside reverse transcriptase inhibitor (NRTI), a type of antiretroviral medication. The Zidosun brand may come in various formulations, including tablets containing zidovudine alone or in combination with other compositions like lamivudine and nevirapine, as seen with "Zidosun-LN".

Sunrise Remedies is a leading manufacturer of zidovudine medication with the brand names of “Zidosun, Zidosun-LD DT Jr., Zidosun-L, and Zidosun-LN; also, a top exporter